Presentation is loading. Please wait.

Presentation is loading. Please wait.

PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors Scott Kopetz 1, Jayesh Desai 2, Emily Chan 3, J Randolph Hecht 4, Peter J O’Dwyer.

Similar presentations


Presentation on theme: "PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors Scott Kopetz 1, Jayesh Desai 2, Emily Chan 3, J Randolph Hecht 4, Peter J O’Dwyer."— Presentation transcript:

1 PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors Scott Kopetz 1, Jayesh Desai 2, Emily Chan 3, J Randolph Hecht 4, Peter J O’Dwyer 5, Richard J Lee 6, Keith B Nolop 7, Suman Bhattacharya 8, Leonard Saltz 9 1 The University of Texas M.D. Anderson Cancer Center, Houston, TX; 2 Royal Melbourne Hospital, Parkville, Australia; 3 Vanderbilt-Ingram Cancer Center, Nashville, TN; 4 David Geffen School of Medicine at UCLA, Los Angeles, CA; 5 Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA; 6 Roche, Nutley, NJ; 7 Plexxikon, Berkeley, CA; 8 Genentech, Inc., South San Francisco, CA; 9 Memorial Sloan-Kettering Cancer Center, New York, NY

2 Kopetz, Desai, et al ASCO 2010 Abs# 3534

3

4

5

6

7

8

9

10

11

12

13

14

15


Download ppt "PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors Scott Kopetz 1, Jayesh Desai 2, Emily Chan 3, J Randolph Hecht 4, Peter J O’Dwyer."

Similar presentations


Ads by Google